Developed tumors were further validated by the expression of GPC3 (an HCC biomarker) and CK19 (an intrahepatic cholangiocarcinoma biomarker) (Figure S1F) 28, 29. The gene discussed is GPC3; the disease is hepatocellular carcinoma.